Indirect protection from rotavirus vaccines: a systematic review

Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden. This systematic review summarizes estimates of indirect protection from rotavirus vaccines and the methods used to obtain these estimates. We identified 71 studies publishe...

Full description

Saved in:
Bibliographic Details
Published inExpert review of vaccines Vol. 23; no. 1; pp. 789 - 795
Main Authors Chavers, Tyler, Cates, Jordan, Burnett, Eleanor, Parashar, Umesh D., Tate, Jacqueline E.
Format Journal Article
LanguageEnglish
Published England Taylor & Francis Group 2024
Subjects
Online AccessGet full text
ISSN1476-0584
1744-8395
1744-8395
DOI10.1080/14760584.2024.2395534

Cover

Abstract Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden. This systematic review summarizes estimates of indirect protection from rotavirus vaccines and the methods used to obtain these estimates. We identified 71 studies published between 2009 and 2022 that provided 399 estimates of indirect protection from rotavirus vaccine. Most estimates (73%) evaluated hospitalizations due to rotavirus gastroenteritis as the outcome and unvaccinated children <5 years old as the agegroup (64%), but there was considerable variability in methods to evaluate indirect protection. For hospitalizations due to rotavirus gastroenteritis among unvaccinated children <5 years old, the median incidence rate ratio was 0.60 (IQR: 0.40-0.87,  = 110 estimates), the median relative percent change in percent positivity was 25% (IQR: 13-44%,  = 49 estimates), and the median relative percent change in absolute number of rotavirus positive tests or rotavirus-specific International Classification of Diseases codes was 42% (IQR: 16-66%,  = 40 estimates). These findings broadly suggest rotavirus vaccines provide some indirect protection. There is a need to standardize measurement of indirect rotavirus vaccine protection, particularly using consistent outcomes and metrics, and stratifying results by standardized age groups and years since vaccine introduction.
AbstractList Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden.INTRODUCTIONRotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden.This systematic review summarizes estimates of indirect protection from rotavirus vaccines and the methods used to obtain these estimates.METHODSThis systematic review summarizes estimates of indirect protection from rotavirus vaccines and the methods used to obtain these estimates.We identified 71 studies published between 2009 and 2022 that provided 399 estimates of indirect protection from rotavirus vaccine. Most estimates (73%) evaluated hospitalizations due to rotavirus gastroenteritis as the outcome and unvaccinated children <5 years old as the agegroup (64%), but there was considerable variability in methods to evaluate indirect protection. For hospitalizations due to rotavirus gastroenteritis among unvaccinated children <5 years old, the median incidence rate ratio was 0.60 (IQR: 0.40-0.87, n = 110 estimates), the median relative percent change in percent positivity was 25% (IQR: 13-44%, n = 49 estimates), and the median relative percent change in absolute number of rotavirus positive tests or rotavirus-specific International Classification of Diseases codes was 42% (IQR: 16-66%, n = 40 estimates).RESULTSWe identified 71 studies published between 2009 and 2022 that provided 399 estimates of indirect protection from rotavirus vaccine. Most estimates (73%) evaluated hospitalizations due to rotavirus gastroenteritis as the outcome and unvaccinated children <5 years old as the agegroup (64%), but there was considerable variability in methods to evaluate indirect protection. For hospitalizations due to rotavirus gastroenteritis among unvaccinated children <5 years old, the median incidence rate ratio was 0.60 (IQR: 0.40-0.87, n = 110 estimates), the median relative percent change in percent positivity was 25% (IQR: 13-44%, n = 49 estimates), and the median relative percent change in absolute number of rotavirus positive tests or rotavirus-specific International Classification of Diseases codes was 42% (IQR: 16-66%, n = 40 estimates).These findings broadly suggest rotavirus vaccines provide some indirect protection. There is a need to standardize measurement of indirect rotavirus vaccine protection, particularly using consistent outcomes and metrics, and stratifying results by standardized age groups and years since vaccine introduction.CONCLUSIONSThese findings broadly suggest rotavirus vaccines provide some indirect protection. There is a need to standardize measurement of indirect rotavirus vaccine protection, particularly using consistent outcomes and metrics, and stratifying results by standardized age groups and years since vaccine introduction.
Introduction Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden.Methods This systematic review summarizes estimates of indirect protection from rotavirus vaccines and the methods used to obtain these estimates.Results We identified 71 studies published between 2009 and 2022 that provided 399 estimates of indirect protection from rotavirus vaccine. Most estimates (73%) evaluated hospitalizations due to rotavirus gastroenteritis as the outcome and unvaccinated children <5 years old as the agegroup (64%), but there was considerable variability in methods to evaluate indirect protection. For hospitalizations due to rotavirus gastroenteritis among unvaccinated children <5 years old, the median incidence rate ratio was 0.60 (IQR: 0.40–0.87, n = 110 estimates), the median relative percent change in percent positivity was 25% (IQR: 13–44%, n = 49 estimates), and the median relative percent change in absolute number of rotavirus positive tests or rotavirus-specific International Classification of Diseases codes was 42% (IQR: 16–66%, n = 40 estimates).Conclusions These findings broadly suggest rotavirus vaccines provide some indirect protection. There is a need to standardize measurement of indirect rotavirus vaccine protection, particularly using consistent outcomes and metrics, and stratifying results by standardized age groups and years since vaccine introduction.
Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden. This systematic review summarizes estimates of indirect protection from rotavirus vaccines and the methods used to obtain these estimates. We identified 71 studies published between 2009 and 2022 that provided 399 estimates of indirect protection from rotavirus vaccine. Most estimates (73%) evaluated hospitalizations due to rotavirus gastroenteritis as the outcome and unvaccinated children <5 years old as the agegroup (64%), but there was considerable variability in methods to evaluate indirect protection. For hospitalizations due to rotavirus gastroenteritis among unvaccinated children <5 years old, the median incidence rate ratio was 0.60 (IQR: 0.40-0.87,  = 110 estimates), the median relative percent change in percent positivity was 25% (IQR: 13-44%,  = 49 estimates), and the median relative percent change in absolute number of rotavirus positive tests or rotavirus-specific International Classification of Diseases codes was 42% (IQR: 16-66%,  = 40 estimates). These findings broadly suggest rotavirus vaccines provide some indirect protection. There is a need to standardize measurement of indirect rotavirus vaccine protection, particularly using consistent outcomes and metrics, and stratifying results by standardized age groups and years since vaccine introduction.
Author Tate, Jacqueline E.
Cates, Jordan
Chavers, Tyler
Burnett, Eleanor
Parashar, Umesh D.
AuthorAffiliation 1 Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
AuthorAffiliation_xml – name: 1 Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Author_xml – sequence: 1
  givenname: Tyler
  surname: Chavers
  fullname: Chavers, Tyler
– sequence: 2
  givenname: Jordan
  surname: Cates
  fullname: Cates, Jordan
– sequence: 3
  givenname: Eleanor
  surname: Burnett
  fullname: Burnett, Eleanor
– sequence: 4
  givenname: Umesh D.
  surname: Parashar
  fullname: Parashar, Umesh D.
– sequence: 5
  givenname: Jacqueline E.
  surname: Tate
  fullname: Tate, Jacqueline E.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39167375$$D View this record in MEDLINE/PubMed
BookMark eNqFUU1PHSEUJY2mfvUn1Myym1EYYAC7qI1R-xITN7omDFwsZmZ4hXmv8d_L-J6mduOGy7mcc-4N5wDtjHEEhL4SfEKwxKeEiRZzyU4a3JSDKs4p-4T2iWCslgXulHvh1DNpDx3k_IgxZYqLz2iPKtIKKvg-Ol-MLiSwU7VMcSo1xLHyKQ5VgWYd0ipXa2NtGCGfVabKT3mCwUzBVgnWAf4eoV1v-gxftvUQ3V9d3l38qm9urxcXP29qy4ScatJCRyzFwHjbOVwgcdy3gjumVOsaKzyzWDjXGGmlA-Y9F5QJjp1qjKL0EC02vi6aR71MYTDpSUcT9EsjpgdtUlmrB20k7xS3kgAQxj3tBDHQqa4lnDBvZPH6sfFarroBnIVxSqZ_Z_r-ZQy_9UNca9IQLHgzO3zbOqT4ZwV50kPIFvrejBBXWVOsePlhiefFj_8d9jblNYNC4BuCTTHnBP6NQrCes9avWes5a73Nuui-_6ezYTJzgGXn0H-gfgYgsa6L
CitedBy_id crossref_primary_10_1016_j_cej_2024_158522
Cites_doi 10.1097/EDE.0b013e31825fb7a0
10.1093/oxfordjournals.aje.a009196
10.1016/j.vaccine.2016.11.056
10.1093/oxfordjournals.epirev.a036147
10.1080/14760584.2022.2066524
10.1080/21645515.2018.1514225
10.1016/j.vaccine.2009.08.030
10.4269/ajtmh.17-0705
10.1080/14760584.2018.1443008
10.1093/oxfordjournals.aje.a115884
10.1136/bmj.n71
10.1093/infdis/jiaa081
10.1080/14760584.2018.1418665
10.1093/oxfordjournals.aje.a010035
10.1016/j.vaccine.2010.01.014
10.1016/j.vaccine.2015.06.064
10.1186/1471-2458-11-462
10.1016/j.vaccine.2012.09.025
10.1093/jpids/piab114
10.1093/ije/20.1.300
10.1016/S2214-109X(20)30262-X
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1080/14760584.2024.2395534
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1744-8395
EndPage 795
ExternalDocumentID oai_doaj_org_article_a85b95c81ee145f3b71aeb9b61514fa8
PMC12107528
39167375
10_1080_14760584_2024_2395534
Genre Systematic Review
Journal Article
GrantInformation_xml – fundername: Intramural CDC HHS
  grantid: CC999999
GroupedDBID ---
0YH
29G
4.4
53G
5GY
AAYXX
ABEIZ
ABLKL
ABXYU
ACGFS
ADCVX
AECIN
AENEX
AEOZL
AESAV
AFRVT
AGDLA
AHMBA
AIJEM
AIYSM
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
BLEHA
CCCUG
CITATION
CS3
DU5
EBS
F5P
GROUPED_DOAJ
H13
HZ~
IAO
IHR
KYCEM
LJTGL
M4Z
MV1
O9-
P2P
SJN
TCNNB
TDBHL
TFL
TFW
TUROJ
0VX
7X7
88E
8AO
8C1
8FI
8FJ
AAGSP
AAHJP
AANCX
AAOUU
ABJNI
ABJXJ
ABKMU
ABUWG
ACFRI
ADBBV
ADTKB
AFKRA
AGMLL
ALIPV
AN0
BENPR
BNQBC
BPHCQ
BVXVI
CBZEQ
CCPQU
CGR
CUY
CVF
DDEWX
DGYZD
ECM
EIF
EJD
FYUFA
HMCUK
IEA
ITC
M1P
NPM
OVD
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
RNANH
TBQAZ
TEORI
UKHRP
7X8
5PM
ID FETCH-LOGICAL-c478t-16eb1c30e456bd016e1d5f675d4996d2c7f4c07dd2a8c8de4ff5734750d92a933
IEDL.DBID DOA
ISSN 1476-0584
1744-8395
IngestDate Wed Aug 27 01:19:23 EDT 2025
Thu Aug 21 18:37:45 EDT 2025
Fri Sep 05 14:30:43 EDT 2025
Mon Jul 21 06:03:56 EDT 2025
Thu Apr 24 22:58:30 EDT 2025
Wed Sep 10 04:55:35 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords indirect vaccine protection
indirect protection
vaccine
rotavirus
Herd protection
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c478t-16eb1c30e456bd016e1d5f675d4996d2c7f4c07dd2a8c8de4ff5734750d92a933
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
ObjectType-Review-4
content type line 23
Author contribution statement: All authors should have substantially contributed to the conception and design of the review article and interpreting the relevant literature and were involved in writing the review article or revised it for intellectual content.
OpenAccessLink https://doaj.org/article/a85b95c81ee145f3b71aeb9b61514fa8
PMID 39167375
PQID 3095673803
PQPubID 23479
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_a85b95c81ee145f3b71aeb9b61514fa8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12107528
proquest_miscellaneous_3095673803
pubmed_primary_39167375
crossref_primary_10_1080_14760584_2024_2395534
crossref_citationtrail_10_1080_14760584_2024_2395534
PublicationCentury 2000
PublicationDate 2024-00-00
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 2024-00-00
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Expert review of vaccines
PublicationTitleAlternate Expert Rev Vaccines
PublicationYear 2024
Publisher Taylor & Francis Group
Publisher_xml – name: Taylor & Francis Group
References e_1_3_5_18_1
e_1_3_5_17_1
e_1_3_5_16_1
e_1_3_5_15_1
e_1_3_5_13_1
e_1_3_5_14_1
e_1_3_5_24_1
e_1_3_5_11_1
e_1_3_5_23_1
e_1_3_5_12_1
e_1_3_5_22_1
e_1_3_5_19_1
e_1_3_5_3_1
e_1_3_5_9_1
e_1_3_5_21_1
e_1_3_5_8_1
e_1_3_5_10_1
e_1_3_5_20_1
e_1_3_5_5_1
e_1_3_5_4_1
e_1_3_5_7_1
e_1_3_5_6_1
References_xml – ident: e_1_3_5_5_1
  doi: 10.1097/EDE.0b013e31825fb7a0
– ident: e_1_3_5_6_1
  doi: 10.1093/oxfordjournals.aje.a009196
– ident: e_1_3_5_11_1
  doi: 10.1016/j.vaccine.2016.11.056
– ident: e_1_3_5_17_1
  doi: 10.1093/oxfordjournals.epirev.a036147
– ident: e_1_3_5_24_1
  doi: 10.1080/14760584.2022.2066524
– ident: e_1_3_5_18_1
– ident: e_1_3_5_12_1
  doi: 10.1080/21645515.2018.1514225
– ident: e_1_3_5_10_1
  doi: 10.1016/j.vaccine.2009.08.030
– ident: e_1_3_5_14_1
  doi: 10.4269/ajtmh.17-0705
– ident: e_1_3_5_19_1
  doi: 10.1080/14760584.2018.1443008
– ident: e_1_3_5_15_1
  doi: 10.1093/oxfordjournals.aje.a115884
– ident: e_1_3_5_22_1
  doi: 10.1136/bmj.n71
– ident: e_1_3_5_3_1
  doi: 10.1093/infdis/jiaa081
– ident: e_1_3_5_23_1
  doi: 10.1080/14760584.2018.1418665
– ident: e_1_3_5_20_1
  doi: 10.1093/oxfordjournals.aje.a010035
– ident: e_1_3_5_7_1
  doi: 10.1016/j.vaccine.2010.01.014
– ident: e_1_3_5_13_1
  doi: 10.1016/j.vaccine.2015.06.064
– ident: e_1_3_5_8_1
  doi: 10.1186/1471-2458-11-462
– ident: e_1_3_5_9_1
  doi: 10.1016/j.vaccine.2012.09.025
– ident: e_1_3_5_4_1
  doi: 10.1093/jpids/piab114
– ident: e_1_3_5_16_1
  doi: 10.1093/ije/20.1.300
– ident: e_1_3_5_21_1
  doi: 10.1016/S2214-109X(20)30262-X
SSID ssj0034957
Score 2.3926668
SecondaryResourceType review_article
Snippet Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden. This systematic review...
Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden.INTRODUCTIONRotavirus vaccines...
Introduction Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden.Methods This...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 789
SubjectTerms Child, Preschool
Gastroenteritis - epidemiology
Gastroenteritis - immunology
Gastroenteritis - prevention & control
Gastroenteritis - virology
Herd protection
Hospitalization - statistics & numerical data
Humans
indirect protection
indirect vaccine protection
Infant
rotavirus
Rotavirus - immunology
Rotavirus Infections - epidemiology
Rotavirus Infections - immunology
Rotavirus Infections - prevention & control
Rotavirus Vaccines - administration & dosage
Rotavirus Vaccines - immunology
vaccine
Title Indirect protection from rotavirus vaccines: a systematic review
URI https://www.ncbi.nlm.nih.gov/pubmed/39167375
https://www.proquest.com/docview/3095673803
https://pubmed.ncbi.nlm.nih.gov/PMC12107528
https://doaj.org/article/a85b95c81ee145f3b71aeb9b61514fa8
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NSx0xEA8iFLyUttp2-0UEr1uz-XhJeqotigp6UvC2TD6WCmUtvvcE__vObHafvlLw4mVhsxs2zMxmfpNkfsPYnks2JQ9QRxe7Wgc9qwMEjbYcBWQrJATKdz47nx1f6tMrc_Wo1BedCSv0wEVw--BM8Ca6JudGm04F20AOPpAn1h0Mab7CiymYKnOwQtg_lFXRFuNl9LFT7o4T-9RGTRgbSrwob4zSa15pIO__H-L89-DkI0909Iq9HCEkPyhDf802cv-GvShFJe-32feTvvgpPnIwoOQ5ZZFwvIW769vlnN9BpA31-TcO_IHLmZc8lh12eXR48fO4Husk1FFbt6ibGU64UYmMYCgkxHC5SabDSCBhODNLMtpOR4E6keCiS1l3nbFKI1ZIXoJX6i3b7G_6_J5xDDCUTV50MlkN4INubAJJBAIxyigrpic5tXEkEadaFr_bZuQancTbknjbUbwV-7rq9qewaDzV4QcpYfUykWAPDWga7Wga7VOmUbHdSYUt_jS0EwJ9vlnOW0X0i1Y5oSr2rqh09SnKRLbKmoq5NWWvjWX9SX_9ayDmJjI2a6T78Byj_8i2SCJluecT21zcLvNnBECL8GWw9b8ck__w
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Indirect+protection+from+rotavirus+vaccines%3A+a+systematic+review&rft.jtitle=Expert+review+of+vaccines&rft.au=Chavers%2C+Tyler&rft.au=Cates%2C+Jordan&rft.au=Burnett%2C+Eleanor&rft.au=Parashar%2C+Umesh+D&rft.date=2024&rft.issn=1744-8395&rft.eissn=1744-8395&rft.volume=23&rft.issue=1&rft.spage=789&rft_id=info:doi/10.1080%2F14760584.2024.2395534&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-0584&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-0584&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-0584&client=summon